Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Long-Term Debt Repayments (2022 - 2023)

bioAffinity Technologies (BIAF) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $42334.0 as the latest value for Q3 2023.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $42334.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $576746.0, a N/A change, with the full-year FY2022 number at $425000.0, changed N/A from a year prior.
  • Long-Term Debt Repayments was $42334.0 for Q3 2023 at bioAffinity Technologies, down from $126096.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $325000.0 in Q4 2022 to a low of $42334.0 in Q3 2023.